Доброкачественная лимфоплазия кожи: диагностика и лечение

1. Lugovic-Mihic L, Duvancic T, Situm M et al. Actinic reticuloid – photosensitivity or pseudolymphoma? A review. Coll Antropol 2011; 35 (Suppl. 2): 325–9.
2. Terada T. Cutaneous pseudolymphoma: a case report with an immunohistochemical study. Int J Clin Exp Pathol 2013; 6 (5): 966–72.
3. Laban E, Beylot-Barry M, Ortonne N et al. Cutaneous lymphoproliferations: Proposal for the use of diagnostic algorithms based on 2760 cases of cutaneous lymphoproliferations taken from the INCa networks over a two-year period. Ann Pathol 2015; 35: 131–47.
4. Safa G, Luce K, Darrieux L et al. Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy. 
J Am Acad Dermatol 2014; 71: 149–50.
5. Iida T, Hamada K, Watanabe H et al. Drug eruption caused by tocilizumab. Visual Dermatol 2014; 13: 2.
6. Imafuku S, Ito K, Nakayama J. Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis. Br J Dermatol 2012; 166: 675–8.
7. Kitagawa KH, Grassi M. Zoledronic acid-induced cutaneous B-cell pseudolymphoma. J Am Acad Dermatol 2011; 65: 1238–40.
8. Олисова О.Ю. Псевдолимфомы кожи. Автореф. дисс. … док. мед. наук. М., 2002. / Olisova O.Iu. Psevdolimfomy kozhi. Avtoref. diss. … dok. med. nauk. M., 2002. [in Russian]
9. Олисова О.Ю., Потекаев Н.С. Псевдолимфомы кожи. М.: Практика, 2013. / Olisova O.Iu., Potekaev N.S. Psevdolimfomy kozhi. M.: Praktika, 2013. [in Russian]
10. Потекаев Н.С., Олисова О.Ю., Теплюк Н.П., Пинегин В.Б. К лечению лимфоцитомы. Рос. журн. кожных и венерических болезней. 2011; 6: 9–11. / Potekaev N.S., Olisova O.Iu., Tepliuk N.P., Pinegin V.B. K lecheniiu limfotsitomy. Ros. zhurn. kozhnykh i venericheskikh boleznei. 2011; 6: 9–11. [in Russian]
11. Cerroni L. Skin Lymphoma: The Illustrated Guide. Wiley-Blackwell, 2014; 4th ed.
12. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768.
13. Sarantopoulos GP, Palla B, Said J et al. Mimics of cutaneous lymphoma: Report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J ClinPathol 2013; 139: 536–51.
14. Kuo WE, Richwine EE, Sheehan DJ. Pseudolymphomatous and lichenoid reaction to a red tattoo: a case report. Cutis 2011; 87 (2): 89–92.
15. Сергеев Ю.В. Доброкачественная лимфоплазия кожи (новое в клинике, морфологии и лечении). Автореф. дисс. … канд. мед. наук. М., 1982. / Sergeev Iu.V. Dobrokachestvennaia limfoplaziia kozhi (novoe v klinike, morfologii i lechenii). Avtoref. diss. … kand. med. nauk. M., 1982. [in Russian]
16. Taylor RB, Fortney JA, Pollack RB et al. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol 2010; 28: 385–7.
17. Shetty SK, Jagadish UHL, Shetty Ch. Pseudolymphoma versus lymphoma: An important diagnostic decision; J Oral Maxillofac Pathol 2016; 20 (2): 328.
18. O'Neill J, Fien S, Zeitouni NC. ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report. J Drugs Dermatol 2010; 9 (6): 688–9.
19. Martin SJ, Duvic M. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin Lymphoma Myeloma Leuk 2011; 11 (3); 286–8.
20. Bergman R. Pseudolymphoma and cutaneous lymphoma: facts and controversies. Clin Dermatol 2010; 28 (5): 568–74.
21. Олисова О.Ю., Теплюк Н.П., Гаранян Л.Г., Пятилова П.М. Доброкачественная лимфоплазия кожи, развившаяся на месте татуировки. Рос. журн. кожных и венерических болезней. 2015; 2: 23–5. / Olisova O.Yu., Tepliuk N.P., Garanian L.G., Piatilova P.M. Dobrokachestvennaia limfoplaziia kozhi, razvivshaiasia na meste tatuirovki. Ros. zhurn. kozhnykh i venericheskikh boleznei. 2015; 2: 23–5. [in Russian]

________________________________________________

1. Lugovic-Mihic L, Duvancic T, Situm M et al. Actinic reticuloid – photosensitivity or pseudolymphoma? A review. Coll Antropol 2011; 35 (Suppl. 2): 325–9.
2. Terada T. Cutaneous pseudolymphoma: a case report with an immunohistochemical study. Int J Clin Exp Pathol 2013; 6 (5): 966–72.
3. Laban E, Beylot-Barry M, Ortonne N et al. Cutaneous lymphoproliferations: Proposal for the use of diagnostic algorithms based on 2760 cases of cutaneous lymphoproliferations taken from the INCa networks over a two-year period. Ann Pathol 2015; 35: 131–47.
4. Safa G, Luce K, Darrieux L et al. Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy. 
J Am Acad Dermatol 2014; 71: 149–50.
5. Iida T, Hamada K, Watanabe H et al. Drug eruption caused by tocilizumab. Visual Dermatol 2014; 13: 2.
6. Imafuku S, Ito K, Nakayama J. Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis. Br J Dermatol 2012; 166: 675–8.
7. Kitagawa KH, Grassi M. Zoledronic acid-induced cutaneous B-cell pseudolymphoma. J Am Acad Dermatol 2011; 65: 1238–40.
8. Olisova O.Iu. Psevdolimfomy kozhi. Avtoref. diss. … dok. med. nauk. M., 2002. [in Russian]
9. Olisova O.Iu., Potekaev N.S. Psevdolimfomy kozhi. M.: Praktika, 2013. [in Russian]
10. Potekaev N.S., Olisova O.Iu., Tepliuk N.P., Pinegin V.B. K lecheniiu limfotsitomy. Ros. zhurn. kozhnykh i venericheskikh boleznei. 2011; 6: 9–11. [in Russian]
11. Cerroni L. Skin Lymphoma: The Illustrated Guide. Wiley-Blackwell, 2014; 4th ed.
12. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768.
13. Sarantopoulos GP, Palla B, Said J et al. Mimics of cutaneous lymphoma: Report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J ClinPathol 2013; 139: 536–51.
14. Kuo WE, Richwine EE, Sheehan DJ. Pseudolymphomatous and lichenoid reaction to a red tattoo: a case report. Cutis 2011; 87 (2): 89–92.
15. Sergeev Iu.V. Dobrokachestvennaia limfoplaziia kozhi (novoe v klinike, morfologii i lechenii). Avtoref. diss. … kand. med. nauk. M., 1982. [in Russian]
16. Taylor RB, Fortney JA, Pollack RB et al. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol 2010; 28: 385–7.
17. Shetty SK, Jagadish UHL, Shetty Ch. Pseudolymphoma versus lymphoma: An important diagnostic decision; J Oral Maxillofac Pathol 2016; 20 (2): 328.
18. O'Neill J, Fien S, Zeitouni NC. ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report. J Drugs Dermatol 2010; 9 (6): 688–9.
19. Martin SJ, Duvic M. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin Lymphoma Myeloma Leuk 2011; 11 (3); 286–8.
20. Bergman R. Pseudolymphoma and cutaneous lymphoma: facts and controversies. Clin Dermatol 2010; 28 (5): 568–74.
21. Olisova O.Yu., Tepliuk N.P., Garanian L.G., Piatilova P.M. Dobrokachestvennaia limfoplaziia kozhi, razvivshaiasia na meste tatuirovki. Ros. zhurn. kozhnykh i venericheskikh boleznei. 2015; 2: 23–5. [in Russian]

Н.П.Теплюк, Т.А.Белоусова*, О.В.Грабовская, В.О.Никурадзе
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 
119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
*belka-1147@mail.ru

________________________________________________

N.P.Tepliuk, T.A.Belousova*, O.V.Grabovskaya, V.O.Nikuradze
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
*belka-1147@mail.ru